beta-D-Galp-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp

Term ID

CHEBI:151049

Synonyms

(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5R,6S)-3,5-Dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
beta-D-galacto-hexopyranosyl-(1->3)-beta-D-galacto-hexopyranosyl-(1->4)-beta-D-gluco-hexopyranose
beta-D-galactopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranose
Gal(b1-3)Gal(b1-4)b-Glc
Gal-(1->3)-Gal-(1->4)-Glcbeta
Galbeta1-3Galbeta1-4Glcbeta
O-beta-D-galactopyranosyl-(1->3)-O-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranose
WURCS=2.0/2,3,2/[a2122h-1b_1-5][a2112h-1b_1-5]/1-2-2/a4-b1_b3-c1

(all 8)

Definition

A linear trisaccharide comprising two beta-D-galactosyl residues and (at the reducing end) a beta-D glucose linked in sequence (1->3) and (1->4).

References

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-Galp-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp

Phenotype where environments contain beta-D-Galp-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp

Phenotype modified by environments containing beta-D-Galp-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp

Phenotype affecting beta-D-Galp-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp

Human Disease Model